Literature DB >> 8329505

Nosocomial outbreak due to Enterococcus faecium highly resistant to vancomycin, penicillin, and gentamicin.

S Handwerger1, B Raucher, D Altarac, J Monka, S Marchione, K V Singh, B E Murray, J Wolff, B Walters.   

Abstract

In October 1990, Enterococcus faecium that was highly resistant to glycopeptides, penicillins, and aminoglycosides was isolated from the peritoneal dialysis fluid from a patient in an intensive care unit. Over the following 6 months, multiresistant E. faecium organisms were isolated from cultures of blood, urine, or surgical wound specimens from eight additional patients. Surveillance cultures of groin and/or rectal swabs were positive for eight of 37 patients and four of 62 employees at risk. Restriction endonuclease digestion of chromosomal DNA from outbreak isolates was consistent with dissemination of a single strain throughout the intensive care unit. Strict infection control interventions contained the outbreak after several weeks. Review of patient charts suggested that renal insufficiency, length of hospital stay, duration of antibiotic treatment, and prior treatment with vancomycin were risks for infection due to multiresistant E. faecium. The emergence of multiple-drug-resistant enterococci presents serious infection control and therapeutic dilemmas.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8329505     DOI: 10.1093/clind/16.6.750

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  87 in total

1.  Molecular epidemiology of vancomycin-resistant Enterococcus faecium in a large urban hospital over a 5-year period.

Authors:  W E Bischoff; T M Reynolds; G O Hall; R P Wenzel; M B Edmond
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

2.  Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients.

Authors:  C J Donskey; T K Chowdhry; M T Hecker; C K Hoyen; J A Hanrahan; A M Hujer; R A Hutton-Thomas; C C Whalen; R A Bonomo; L B Rice
Journal:  N Engl J Med       Date:  2000-12-28       Impact factor: 91.245

Review 3.  Effects of antibiotics on nosocomial epidemiology of vancomycin-resistant enterococci.

Authors:  Stephan Harbarth; Sara Cosgrove; Yehuda Carmeli
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

Review 4.  Relationships between enterococcal virulence and antimicrobial resistance.

Authors:  L M Mundy; D F Sahm; M Gilmore
Journal:  Clin Microbiol Rev       Date:  2000-10       Impact factor: 26.132

Review 5.  Vancomycin-resistant enterococci.

Authors:  Y Cetinkaya; P Falk; C G Mayhall
Journal:  Clin Microbiol Rev       Date:  2000-10       Impact factor: 26.132

6.  Effective cohorting and "superisolation" in a single intensive care unit in response to an outbreak of diverse multi-drug-resistant organisms.

Authors:  Laura H Rosenberger; Tjasa Hranjec; Amani D Politano; Brian R Swenson; Rosemarie Metzger; Hugo Bonatti; Robert G Sawyer
Journal:  Surg Infect (Larchmt)       Date:  2011-09-21       Impact factor: 2.150

7.  Prevalence of vancomycin-resistant enterococci in fecal samples from hospitalized patients and nonhospitalized controls in a cattle-rearing area of France.

Authors:  K Gambarotto; M C Ploy; P Turlure; C Grélaud; C Martin; D Bordessoule; F Denis
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

8.  Molecular diversity and evolutionary relationships of Tn1546-like elements in enterococci from humans and animals.

Authors:  R J Willems; J Top; N van den Braak; A van Belkum; D J Mevius; G Hendriks; M van Santen-Verheuvel; J D van Embden
Journal:  Antimicrob Agents Chemother       Date:  1999-03       Impact factor: 5.191

9.  Resistance of Enterococcus faecium to neutrophil-mediated phagocytosis.

Authors:  R C Arduino; K Jacques-Palaz; B E Murray; R M Rakita
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

10.  Selective isolation of vancomycin-resistant enterococci.

Authors:  K G van Horn; C A Gedris; K M Rodney
Journal:  J Clin Microbiol       Date:  1996-04       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.